Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04898491

Validity and Reliability Study of the Pain Indicator Behavior Scale-Brain Damage (ESCID-DC)

Validity and Reliability Study of the Pain Indicator Behavior Scale Adapted to Measure Pain in Critically Ill Patients With Acquired Brain Damage, Non-communicative and With an Artificial Airway (ESCID-DC).

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Candelas Lopez Lopez · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A multicentre observational study to validate the adaptation of the Pain Indicator Behavior Scale (ESCID) for patients with acquired Brain Damage (ESCID-DC), as a measuring instrument.

Detailed description

Non-commercial study. The study complies with the ethical principles of the Declaration of Helsinki, the recommendations of Good Clinical Practice (GCP) and current legislation. The study has been approved with a favorable opinion by the CEIm of the Hospital Universitario 12 de Octubre. Written consent will be requested from the participants and / or their relatives / representatives to participate in the study.

Conditions

Interventions

TypeNameDescription
OTHERPain assessment using a behavioral scaleThe pain of the subjects will be evaluated by two independent observers and with a blind result between them, coinciding with the application of two painful procedures used in routine practice: suction of tracheal secretions and the pressure in the nail bed by means of a pressure algometer. In addition, a painless procedure will also be performed to establish an element of control with the procedures painful. This will consist of the application of gentle friction with a cloth gauze, on a part of healthy skin tissue of the patient. The measurement will be performed twice for each patient and procedure depending on the level of sedation, so that the first measurement will be performed with a deeper sedation level and the second with a change in sedation level to moderate-mild. In turn, the pain assessment will be carried out in three moments: first or baseline measurement, during the application of the painless and 15 minutes after finishing the procedures.

Timeline

Start date
2022-06-01
Primary completion
2023-12-31
Completion
2025-06-30
First posted
2021-05-24
Last updated
2025-04-02

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04898491. Inclusion in this directory is not an endorsement.